Atlas Trials

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Clinical trial NCT01191008 · COMPLETED

Trial details

NCT number
NCT01191008
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
GlaucomaOcular Hypertension
Start date
2010-10-01
Primary completion
2015-05-01
Enrollment
661

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.